Stocks
HealthEquity (HQY) R&D/CAPEX US GAAP (year values) |
|||||||||
| 2022 | 2023 | 2023 | 2024 | 2024 | LTM ? | CAGR 5 years ? | |||
| R&D/CAPEX, % | 114.8% | 398.3% | 162.3% | 511.0% | 474.9% | 45.2% | |||
| Changes by years, y/y, % | -14pp | +284pp | -236pp | +349pp | -36pp | +15.3% | |||
HealthEquity. R&D/CAPEX, %
HealthEquity. R&D/CAPEX, changes, pp
HealthEquity (HQY) R&D/CAPEX US GAAP (quarter values) |
||||||||
| 2024Q3 | 2024Q4 | 2024Q4 | 2025Q1 | 2025Q2 | LTM ? | |||
| R&D/CAPEX, % | 360.7% | 689.4% | 490.1% | 20.8% | 28.0% | 45.2% | ||
| Changes by years, y/y, % | -1pp | +176pp | -23pp | -562pp | -506pp | |||
| Changes by quarters, q/q, % | -174pp | +329pp | -199pp | -469pp | +7pp | |||
